Develops epigenetic biomarkers for life insurance underwriting.
Jun 2026Revenue $17.9M/yrExpenses $18.7M/yr
No trendCash runway ≈ 1 month from Jun 2026
Figures by year
When will Foxo Technologies be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $17.9M and expenses $18.7M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $16.4M | $26.7M | −$10.3M |
| Dec 2024 | $4.05M | $11.8M | −$7.76M |
| Dec 2023 | $145K | $22.3M | −$22.2M |
| Dec 2022 | $511K | $40.7M | −$40.2M |
| Dec 2021 | $120K | $15.2M | −$15.0M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.